Steven Oliveira
Präsident bei Oliveira Capital LLC
Vermögen: 311 682 $ am 30.04.2024
Profil
Steven M.
Oliveira is the founder of SIGA Technologies, Inc. founded in 1995.
He is also the founder of Assertio Therapeutics, Inc. Mr. Oliveira's current job is President at Oliveira Capital LLC since 2002.
Mr. Oliveira's former jobs include Director at Repros Therapeutics, Inc., Director at Ideanomics, Inc. from 2010 to 2011, Independent Director at Pulte Acquisition Corp., Chief Investment Officer at Chardan SPAC Asset Management LLC from 2008 to 2013, and Managing Partner at CSO Ventures.
Mr. Oliveira received his undergraduate degree from Manhattan College in 1989.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BENITEC BIOPHARMA INC
0,48% | 22.04.2024 | 44 911 ( 0,48% ) | 311 682 $ | 30.04.2024 |
Aktive Positionen von Steven Oliveira
| Unternehmen | Position | Beginn |
|---|---|---|
| Oliveira Capital LLC | Präsident | 01.01.2002 |
Ehemalige bekannte Positionen von Steven Oliveira
| Unternehmen | Position | Ende |
|---|---|---|
| Chardan SPAC Asset Management LLC | Chief Investment Officer | 01.01.2013 |
| IDEANOMICS, INC. | Direktor/Vorstandsmitglied | 30.03.2011 |
| REPROS THERAPEUTICS INC | Direktor/Vorstandsmitglied | - |
| SIGA TECHNOLOGIES, INC. | Gründer | - |
| CSO Ventures | Corporate Officer/Principal | - |
Ausbildung von Steven Oliveira
| Manhattan College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SIGA TECHNOLOGIES, INC. | Health Technology |
| IDEANOMICS, INC. | Consumer Durables |
| Private Unternehmen | 6 |
|---|---|
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
| Oliveira Capital LLC | |
| Chardan SPAC Asset Management LLC | |
Pulte Acquisition Corp.
 Pulte Acquisition Corp. MiscellaneousMiscellaneous Pulte Acquisition Corp. operates as a blank check company. The company is headquartered in Chicago, IL. | Miscellaneous |
| CSO Ventures |
